Jenny Robertson
Formerly Chief Legal Officer Lexeo Therapeutics
Seminars
Wednesday 5th August 2026
Panel Discussion: Strengthening IPO Readiness to Reduce Liability Exposure & Support Defensible Board Decision‑Making
3:15 pm
- Build disclosure discipline early by aligning scientific claims, press releases, BD decks, and public statements to withstand S‑1 scrutiny
- Reduce litigation and enforcement risk through structured risk‑factor design and clear escalation controls
- Strengthen board decision‑making with disciplined go/no‑go criteria, documentation standards, and scenario pathways
- Prepare for life as a public company by aligning IPO readiness with post‑IPO ongoing public company obligations, capital markets strategy, contingency planning, and dual‑track financing scenarios
Wednesday 5th August 2026
Panel Discussion: Stabilizing Development Momentum to Preserve Market Confidence During Regulatory Volatility
9:15 am
- Maintain investor and partner confidence by aligning regulatory pivots with disciplined communications
- Protect timelines and budgets by responding decisively to CRLs, endpoint shifts, and evolving agency expectations
- Strengthen resilience by leveraging patient advocacy, public affairs, and cross-functional escalation pathways during periods of agency uncertainty
Wednesday 5th August 2026
Chair’s Opening Remarks
9:00 am
Wednesday 5th August 2026
Chair’s Closing Remarks
5:00 pm
